Maurizio Voi
CIK 1534579 · View on SEC EDGAR ↗
First SEC filing: Jan. 18, 2013 · Latest: Jan. 18, 2013
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Jan. 17, 2013 | CRIS | A | 29,424 | — | — | 29,424 Direct | — | Acquired | (price as of 2026-08-21) |
| Jan. 17, 2013 | CRIS | A | 95,576 | — | — | 95,576 Direct | — | Acquired | (price as of 2026-08-21) |
| Jan. 5, 2012 | CRIS | A | 6,250 | — | — | 6,250 Direct | — | Acquired | (price as of 2026-08-21) |
| Jan. 5, 2012 | CRIS | A | 93,750 | — | — | 93,750 Direct | — | Acquired | (price as of 2026-08-21) |
| Nov. 8, 2011 | CRIS | A | 106,380 | — | — | 350,000 Direct | +43.67% | Acquired | (price as of 2026-08-21) |
| Nov. 8, 2011 | CRIS | A | 243,620 | — | — | 243,620 Direct | — | Acquired | (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Jan. 17, 2013 | CRIS | Non-qualified stock option (right to buy) | Common stock (29,424) | $3.32 | Jan. 17, 2023 | 29,424 | Acquired |
| Jan. 17, 2013 | CRIS | Qualified stock option (right to buy) | Common stock (95,576) | $3.32 | Jan. 17, 2023 | 95,576 | Acquired |
| Jan. 5, 2012 | CRIS | Qualified stock option (right to buy) | Common stock (6,250) | $4.52 | Jan. 5, 2022 | 6,250 | Acquired |
| Jan. 5, 2012 | CRIS | Non-qualified stock option (right to buy) | Common stock (93,750) | $4.52 | Jan. 5, 2022 | 93,750 | Acquired |
| Nov. 8, 2011 | CRIS | Qualified stock option (right to buy) | Common stock (106,380) | $3.76 | Nov. 8, 2021 | 106,380 | Acquired |
| Nov. 8, 2011 | CRIS | Non-qualified stock option (right to buy) | Common stock (243,620) | $3.76 | Nov. 8, 2021 | 243,620 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
CRIS
EVP| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2013 | — | — | — | — | — | — | — | — |
| 2012 | $40,000,057,692 | $10,500,026,000 | — | — | — | — | $80,661,692 | $884,331,953,924 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.